Chlamydia vaccine (GlaxoSmithKline)

N/A

Report date: 2025/03/20 09:51:11

Base Information

Drug NameChlamydia vaccine (GlaxoSmithKline)

Drug Alias NameChlamydia vaccine (Corixa/GlaxoSmithKline)Chlamydia trachomatis vaccine (Corixa/GlaxoSmithKline)Chlamydia vaccine (Corixa/SmithKline Beecham)

ClassificationVaccines

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsChlamydia Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCorixa Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc Corixa Corp Smithkline Beecham Plc

Active IndicationsN/A

Inactive IndicationsChlamydia Infections

Other Information

ATC CodeN/A